Patient safety is, and will always remain, Lilly’s highest priority Eli Lilly and Company (India) commends the actions taken by the Haryana drug control authority in addressing counterfeit products falsely bearing the Mounjaro® (tirzepatide) brand name that were recently seized in Gurugram, Haryana. These seized counterfeit
Forecasts to invest an estimated Rs. 1,000 cr over 5 years Revolutionizing Medtech Access and Empowering Radiologists One clinic setup requires an estimated Rs. 3.5 cr for an independent radiologist Reaching over 1 million patients annually Truevis Technologies Pvt Limited, a leading manufacturer in the med-tech sector, and Neusoft
The Delhi High Court has dismissed a plea challenging the Food Safety and Standards Authority of India (FSSAI)’s directive banning the sale of beverages marketed under the guise of ‘ORS’ (Oral Rehydration Salts) formulations, reaffirming the regulator’s authority to act in the interest of public
The Delhi High Court has upheld the Food Safety and Standards Authority of India (FSSAI)’s regulatory action against a company for misleading labeling and marketing of an ‘ORS’-branded product, emphasizing that public health must take precedence over commercial interests. The court ruled that the product in
